J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Sanofi's Dupixent Shows Promise for Skin Disease
Regeneron, Sanofi Get FDA Approval for Upper Airway Disease Treatment
Regeneron Pharmaceuticals And Sanofi Announce FDA Approval For Dupixent In The U.S. As First And Only Treatment For Adolescents With Chronic Rhinosinusitis With Nasal Polyps
Pharma Stock Roundup: FDA Approves J&J's Tremfya for Ulcerative Colitis & More
OC/LEP (Oral Contraception, Low Dose Estrogen Progestin) Market Research 2024 Featuring Johnson & Johnson, Sanofi, Novartis, Pfizer, Bayer, Merck, Teva, Abbvie, Viatris, and Cipla